Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-79
SponsorKarolinska Institutet
About this trial
The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.
Eligibility criteria
Qualifiers
a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
age 35-80 years
reading and writing proficiency in Swedish
Disqualifiers
Claustrofobia
Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
Asthma or severe chronic obstructive lung disease
eGFR < 30 ml/min
Trial design
Treatments tested in this trial
- Cardiac magnetic resonance imaging to study coronary microvascular dysfunction
Treatment groups
85 Participants
are divided into 1 treatment groupSponsors and collaborators
Karolinska Institutet
Lead sponsor
Region Stockholm
Collaborator
Source ClinicalTrials.gov